General Mills ( NYSE: GIS) updated on some of its financial progress ahead of an appearance by the management team at the ...
Relay Therapeutics' financial stability is strong, but zero Q3 2024 revenue and rising net losses raise concerns. Find out ...
Operator Welcome to the fourth quarter 2024 Arista Networks financial results earnings conference call. During the call, all participants will be in a listen-only mode. After the presentation, we will ...
Kura Oncology, Inc. (NASDAQ:KURA), a clinical-stage biopharmaceutical company focused on developing precision medicines for ...
Catalyx, a global leader in machine vision, automation and process control products and services for the life science and ...
Day 2 of the Times Group ET NOW Global Business Summit 2025 ended on a high note with a conviction that India is all set to ...
About Janus Henderson Janus Henderson Group is a leading global active asset manager dedicated to helping clients define and achieve superior financial outcomes through differentiated insights ...
Bicycle Therapeutics plc (Nasdaq: NASDAQ:BCYC), a biotechnology company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide ...
PTC Therapeutics, Inc. (NASDAQ: PTCT) announced today that the U.S. Food and Drug Administration (FDA) has accepted for filing the New Drug Application (NDA) for vatiquinone for the ...
Sen. Ted Cruz released a database of over 3,400 National Science Foundation grants awarded towards what he deemed ...
Day 90 biopsy data reported from first 3 participants dosed in Phase 1/2 INSPIRE DUCHENNE trial —— Average microdystrophin expression of 110% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results